1Yin W, Chen B, Tian F, et al. The growth of radiation ontology in China's Mainland during the last 10 years[J]. Int J Radiat Oncol Biol Phys, 2008, 70(3):795-798.
2Levegrun S, Jackson A, Zelefsky MJ, et al. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models [J]. Int J Radiat Oncol Biol Phys, 2000, 47(5):1245-1260.
3Zagars GK, Pollack A, von Eschenbach AC. Prognostic factors for clinically localized prostate carcinoma: analysis Of 938 patients irradiated in the prostate specific antigen era[J]. Cancer, 1997, 79(7):1370-1380.
4Pollack A, Zagars GK, Smith LG, et al. Preliminary results of a randomized dose escalation study comparing 70 Gy to 78 Gy for the treatment of prostate cancer[J]. J Clin Oncol, 2000, 18(23):3904-3911.
5Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer[J]. Int J Radiat Oncol Biol Phys, 1998, 41(3):491-500.
6Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer [J]. J Urol, 2001, 166(3):876-881.
7Hanks GE, Hanlon AL, Pinover WH, et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy[J]. Cancer J Sci Am, 1999, 5(3):152-158.
8Roach III M, Meehan S, Kroll S, et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate[J]. J Urol, 1996, 156(5):1719-1723.
9Leibel SA, Hanks GE, Kramer S. Patterns of care outcomes studies: results of the national practice in adenocarcinoma of the prostate[J]. Int J Radiat Oncol Biol Phys, 1984, 10(3):401-409.
10Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients[J]. J Clin Oncol, 2007, 25 (31):4873-4879.
